Geriatric Medicines Market
According to Intent Market Research, the Geriatric Medicines Market is expected to grow from USD 16.1 billion in 2024-e at a CAGR of 12.5% to touch USD 36.8 billion by 2030. The Geriatric Medicines Market is dominated by key players such as Pfizer Inc., Novartis AG, Johnson & Johnson, Sanofi S.A., Merck & Co., Inc., Roche Holding AG, AstraZeneca PLC, GlaxoSmithKline PLC, Eli Lilly and Co., Bayer AG, AbbVie Inc., Bristol Myers Squibb, Teva Pharmaceutical Industries Ltd., Mylan NV, Amgen Inc.